Results 11 to 20 of about 17,787 (263)

Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018
Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
V. А. Solodovnyk   +2 more
doaj   +1 more source

Drug Utilisation Pattern in the Inpatient Management of Psoriasis: A Retrospective Study from a Tertiary Care Centre in Karnataka, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Psoriasis is a chronic immune-mediated inflammatory disorder that often requires multidrug therapy during hospitalisation. Evaluation of drug utilisation patterns helps assess rational prescribing practices and adherence to treatment ...
D Karthik, Anil Pandhrinath Hogade
doaj   +1 more source

The effect of isotretinoin on triglycerides and liver aminotransferases Influência da isotretinoína nas transaminases hepáticas e triglicerídeos

open access: yesAnais Brasileiros de Dermatologia, 2012
BACKGROUND: Isotretinoin has been used to treat the most severe cases of acne; however, it may provoke adverse events in mucocutaneous and hepatic tissues, lead to alterations in lipid levels and cause teratogenicity.
Andreia Salezze Vieira   +2 more
doaj   +1 more source

Erythrodermic Psoriasis Managed with Risankizumab

open access: yesCase Reports in Dermatology, 2022
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies.
Abdulmajeed Alajlan   +4 more
doaj   +1 more source

Update on pharmacotherapy in psychodermatological disorders

open access: yesIndian Dermatology Online Journal, 2020
Psychodermatological (PD) conditions encountered in dermatologic practice include primary psychiatric conditions such as delusions of parasitosis or secondary psychiatric conditions such as anxiety and depression due to dermatologic disease.
Shrutakirthi D Shenoi   +3 more
doaj   +1 more source

Topical Immunomodulation with Diphenlycyclopropenone for Alopecia Areata

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2019
Introduction: Topical immunotherapy with diphenylcyclopropenone is a treatment option for patients with refractory or extensive alopecia areata. The aim of this study was to evaluate the clinical efficacy and tolerability of diphenylcyclopropenone ...
Ana Sofia Borges   +3 more
doaj   +1 more source

Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery

open access: yesDermatology Research and Practice, 2013
Minor postoperative bleeding is the most common complication of cutaneous surgery. Because of the commonality of this complication, hemostasis is an important concept to address when considering dermatologic procedures.
Jill Henley, Jerry D. Brewer
doaj   +1 more source

Do you know this syndrome? Hand-foot syndrome [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces.
Cintia Santos Braghiroli   +4 more
doaj   +2 more sources

Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial

open access: yesActa Dermato-Venereologica
Scalp psoriasis affects approximately 80% of patients with psoriasis and can negatively impact their quality of life. This post hoc analysis of the VOYAGE 2 Phase III randomized clinical trial evaluated scalp response to guselkumab treatment and its ...
Enikö Sonkoly   +6 more
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy